Lawrence Carin, PhD, Duke’s Vice President for Research, and Greg Eppink, Leica Microsystems Americas, pose with a special glass plaque created for the new Leica Microsystems Center for Excellence at the Light Microscopy Core Facility/ Duke Cancer Institute Light Microscopy Shared Resource. The plaque now graces the entrance to room 377, Nanaline Duke building. (photo by Colin Huth)
Duke and Leica Microsystems Establish Center of Excellence in Microscopy
Published
From the Duke Cancer Institute archives. Content may be out of date.
Duke University and Leica Microsystems, Inc., have formally established a Leica Microsystems Center of Excellence at the Duke University Light Microscopy Core Facility/Duke Cancer Institute Light Microscopy Shared Resource.
The collaboration was made official at a signing ceremony on Wednesday, Feb. 19, between Lawrence Carin, Ph.D., Duke’s Vice President for Research, and Greg Eppink, Leica Microsystems Americas General Manager of Microscopy, followed by a ribbon-cutting.
The center supports a mission to drive new discoveries and insights from scientific research performed using three new Leica imaging systems — the stimulated emission depletion (STED) super-resolution microscope, the Deep in vivo Explorer (DIVE) multiphoton imaging microscope, and the Leica SP8 confocal. This technology allows researchers to capture images and digital movies of the cellular and molecular processes of life.
“A scientist’s insight is only as good as their tools,” said Carin. “We’re very pleased to have this microscopy center on campus to help our investigators see ever deeper into the mysteries of life.”
Director of the Light Microscopy Core Facility, Lisa Cameron, Ph.D., and the microscopy specialists Yasheng Gao, Ph.D., and Benjamin Carlson, Ph.D., who run the day-to-day operations of the core.
Advancing Cancer Science
Colin S. Duckett, Ph.D., Vice Dean for Basic Science at the Duke School of Medicine, emphasized Duke’s commitment to supporting basic biomedical research.
“The fact that our biologists at Duke have the latest-breaking most cutting-edge equipment is obviously a win for us,” he said, addressing the faculty in attendance. “Our job is to lower the barriers so that you can do some fantastic science.”
Leica will support routine maintenance and upgrades of its imaging systems, while the LMCF will give Leica important feedback on functionality and workflow.
“It’s very exciting to be able to advance into the future of scientific research in collaboration with a top-tier institution like Duke,” said Eppink. “With this agreement, we’re enabling researchers to push beyond the boundaries of what can be visualized and quantified. We look forward to continuing this alliance for years to come.”
Carin recognized the “incredible effort” by LMCF director, Lisa Cameron, PhD, in building this new collaboration and lauded her work running the LMCF since August 2016.
“The Light Microscopy Core is one of the most heavily used cores at Duke, fundamental to research across the university,” remarked Carin. “Your leadership is greatly appreciated.”
Christopher Counter, Ph.D., chair of the Duke Cancer Institute Shared Resource Oversight Committee and professor of Pharmacology and Cancer Biology (facing front), chats with fellow DCI member Scott Soderling, Ph.D., chair of the Department of Cell Biology, at the celebratory reception. (photo by Colin Huth)
Partnership
The LMCF was initially formed from several departmental microscope resources in the Levine Science Research Center. The Department of Biology and the Department of Pharmacology & Cancer Biology teamed up, along with the then Comprehensive Cancer Center's Confocal Microscopy Shared Resource, to hire a director in 2006 to establish and run a cooperative microscope facility for the two departments.
The facility received substantial funding from the Office of the Provost and the Dean of the Medical School in 2007 to purchase new equipment and become a resource for the entire Duke community. The facility remains a Duke Cancer Institute (DCI) Shared Resource.
Cameron thanked the university, DCI, and the School of Medicine for their investment in the continuous expansion of the LMCF and its technologies. She also expressed her appreciation for biologist Daniel P. Kiehart, Ph.D., and cancer biologist and DCI member Daniel Julio Lew, Ph.D., who’ve been LMCF advisors since the facility’s founding and for microscopy specialists Yasheng Gao, Ph.D., and Benjamin Carlson, Ph.D., who’ve been running the day-to-day operations of the facility for years.
Cameron also gave a shout-out to Scott Soderling, Ph.D., chair of the Department of Cell Biology and a member of DCI and the Duke Institute for Brain Sciences, for his department’s support in hosting the main LMCF location, Nanaline Duke building.
During a celebratory reception following the ceremony, Cameron, Gao, and Carlson gave informal tours of the new Leica imaging systems to a couple dozen Duke researchers and Duke and Leica officials.
The new Leica imaging systems are housed on campus in room 377 of the Nanaline Duke Building and in room 4229 of the Medical Science Research Building III.
“Leica Microsystems will serve as an excellent partner to help push forward the technology to perform advanced light microscopy imaging on a range of samples that are part of the research going on at Duke University, Duke Cancer Institute (DCI), and the Duke School of Medicine,” said Cameron.
As a centrally funded shared resource, the LMCF’s aim is to offer affordable and efficient access to standard and advanced imaging instrumentation for users of all levels of experience and from any discipline across Duke University and the Duke Medical Center campuses. The LMCF can help with live cells, fixed samples, model organisms, small animals, single-molecule imaging, or at most points in between.
The LMCF houses more than 22 microscope systems and nine image analysis workstations — including Leica, Andor Technologies, Carl Zeiss Imaging, Olympus, General Electric, Hamamatsu, and Molecular Devices — across the core’s four campus locations.
For the first time since 2019, the Duke Cancer Institute Scientific Retreat was held in person with a full program followed by a poster session and mingling. Held on December 2, 2022, the retreat attracted around 90 faculty, staff, and trainees (students, residents, fellows, postdocs, etc.).There was also a virtual option, which an additional 184 individuals took advantage of — whether out of convenience or caution during a season of rising Covid-19, Flu, and RSV infections.“Good afternoon, everybody. It's a pleasure to welcome you to the ninth annual Duke Cancer Institute Scientific Retreat. It's wonderful to be able to be in person again. I know this is a hybrid meeting, so we don't have everyone here. Maybe 15% of the audience is in person — but this is better than zero," said Executive Director of Duke Cancer Institute and host of the event Michael B. Kastan, MD, PhD. "We have a wonderful afternoon planned with selections of the top abstracts from each of the Cancer Center programs, a faculty presentation by Dr. Epplein that we're very much looking forward to, and then our keynote speaker for the Colvin lecture, Peggy Goodell from Baylor will be wrapping up the afternoon prior to the poster session.”Commemorations of DCI's 50th Anniversary as a National Cancer Institute-designated Comprehensive Cancer Center were in evidence in nearly every presenter’s PowerPoint — emphasizing their pride in the tremendous impact of current and former DCI investigators and clinicians on cancer research and patient care in the U.S. and around the world.Seven DCI Trainee Members — one from each of DCI's seven basic, clinical, and translational National Cancer Institute-Designated Research Programs — were selected by program leaders and the scientific review committee to present their research at the retreat. (Previous to the retreat all trainees were invited to submit, for oral-presentation consideration, an abstract on their research project).Six of the trainees received a $1,000 award from the DCI and the trainee with the most innovative basic-science research project, as is customary at the annual retreat, received the Robert and Barbara Bell Basic Science Cancer Research Award in the amount of $5,000.Each trainee was introduced by either their mentor or a research-program faculty leader and took questions after their presentation. Between affirmations, friendly critiques, probing questions, and ideas for further exploration, there was no debating that the learning was infectious.In three presentations, the learnings were literally “infectious.”Meira Epplein, PhD, MS, MA—co-leader with Katherine Garman, MD,of the National Cancer Institute-designated DCI Cancer Risk, Detection and Interception Research Program (CRDI) — plus two of seven top trainees addressed, each from different angles, the bacterial and viral associations with and molecular drivers of gastric cancer, and potential strategies for both treating it and stopping its development before it starts.Other topics of the afternoon included:a patient experience study on barriers and facilitators to care in Black patients with newly diagnosed leukemia (specifically AML);a pathology/immunochemistry computational mapping study — deep learning — to characterize the features of the immune micro-environment landscape;novel approaches for: targeting fusion-driven rhabdomyosarcomas; targeting glioblastoma stem cells, otherwise known as brain-tumor initiating cells; and making breast cancer more receptive to treatment with immunotherapies by using targeted therapy/vaccinationand a review, by the keynote speaker, of the mechanisms that regulate hematopoietic stem cells and how they go awry in blood cancersGastric Cancer in Focus
TheDuke University School of Medicine Department of Head and Neck Surgery & Communication Sciences (HNS&CS) recently launched Project CHECKERS (Community Head and NEck Cancer Knowledge, Engagement, Research and Screening) a Duke Cancer Institute-funded pilot project to bring head and neck cancer resources and education to the broader Durham community.Led by DCI head and neck surgeon Trinitia Cannon, MD, an associate professor in the Department, the project will be the Department’s first community-based participatory research project and the first such head and neck cancer screening and cancer prevention education project in North Carolina.
For the first time since 2019, the Duke Cancer Institute Scientific Retreat was held in person with a full program followed by a poster session and mingling. Held on December 2, 2022, the retreat attracted around 90 faculty, staff, and trainees (students, residents, fellows, postdocs, etc.).There was also a virtual option, which an additional 184 individuals took advantage of — whether out of convenience or caution during a season of rising Covid-19, Flu, and RSV infections.“Good afternoon, everybody. It's a pleasure to welcome you to the ninth annual Duke Cancer Institute Scientific Retreat. It's wonderful to be able to be in person again. I know this is a hybrid meeting, so we don't have everyone here. Maybe 15% of the audience is in person — but this is better than zero," said Executive Director of Duke Cancer Institute and host of the event Michael B. Kastan, MD, PhD. "We have a wonderful afternoon planned with selections of the top abstracts from each of the Cancer Center programs, a faculty presentation by Dr. Epplein that we're very much looking forward to, and then our keynote speaker for the Colvin lecture, Peggy Goodell from Baylor will be wrapping up the afternoon prior to the poster session.”Commemorations of DCI's 50th Anniversary as a National Cancer Institute-designated Comprehensive Cancer Center were in evidence in nearly every presenter’s PowerPoint — emphasizing their pride in the tremendous impact of current and former DCI investigators and clinicians on cancer research and patient care in the U.S. and around the world.Seven DCI Trainee Members — one from each of DCI's seven basic, clinical, and translational National Cancer Institute-Designated Research Programs — were selected by program leaders and the scientific review committee to present their research at the retreat. (Previous to the retreat all trainees were invited to submit, for oral-presentation consideration, an abstract on their research project).Six of the trainees received a $1,000 award from the DCI and the trainee with the most innovative basic-science research project, as is customary at the annual retreat, received the Robert and Barbara Bell Basic Science Cancer Research Award in the amount of $5,000.Each trainee was introduced by either their mentor or a research-program faculty leader and took questions after their presentation. Between affirmations, friendly critiques, probing questions, and ideas for further exploration, there was no debating that the learning was infectious.In three presentations, the learnings were literally “infectious.”Meira Epplein, PhD, MS, MA—co-leader with Katherine Garman, MD,of the National Cancer Institute-designated DCI Cancer Risk, Detection and Interception Research Program (CRDI) — plus two of seven top trainees addressed, each from different angles, the bacterial and viral associations with and molecular drivers of gastric cancer, and potential strategies for both treating it and stopping its development before it starts.Other topics of the afternoon included:a patient experience study on barriers and facilitators to care in Black patients with newly diagnosed leukemia (specifically AML);a pathology/immunochemistry computational mapping study — deep learning — to characterize the features of the immune micro-environment landscape;novel approaches for: targeting fusion-driven rhabdomyosarcomas; targeting glioblastoma stem cells, otherwise known as brain-tumor initiating cells; and making breast cancer more receptive to treatment with immunotherapies by using targeted therapy/vaccinationand a review, by the keynote speaker, of the mechanisms that regulate hematopoietic stem cells and how they go awry in blood cancersGastric Cancer in Focus
TheDuke University School of Medicine Department of Head and Neck Surgery & Communication Sciences (HNS&CS) recently launched Project CHECKERS (Community Head and NEck Cancer Knowledge, Engagement, Research and Screening) a Duke Cancer Institute-funded pilot project to bring head and neck cancer resources and education to the broader Durham community.Led by DCI head and neck surgeon Trinitia Cannon, MD, an associate professor in the Department, the project will be the Department’s first community-based participatory research project and the first such head and neck cancer screening and cancer prevention education project in North Carolina.
